Navigation Links
Dblur Concludes Licensing Deal With STMicroelectronics
Date:2/11/2008

e demanding industry requirements of the mobile imaging market. The STMicroelectronics sensors are key elements in Dblur's 2008 product offering which include off-the-shelf chips and lenses from tier-one vendors around the world."

Notes to the Editor

About Dblur

Founded in 2000, Dblur's proprietary and patented Software Lens(TM) technology addresses current and future challenges facing the mobile imaging industry by enabling low cost, high performance, miniature camera modules. The modules deliver superior optical performance and greater functionality including Extended Depth of Field (EDoF), slim lens profiles, and wide aperture lenses for greater sensitivity in low light applications. Dblur-enabled lenses and chips are available as off-the-shelf products from tier-one sensor and optic lens vendors around the world.

The company is backed by leading international investors and has its head office located in Herzliya, Israel with offices in Europe, Taiwan and Korea.
For more information, please visit our website: http://www.dblur.com

For more information please contact:

Dblur

Mr. Guy Michrowsky

VP Marketing & Sales

Tel: +972-54-444-8314

E-mail: guy@dblur.com


'/>"/>
SOURCE Dblur Software Lens Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dblur Announces the Availability of a Software Lens(TM) Enabled Chip
2. Journal Sleep: Study concludes a daytime nap can benefit a persons memory performance
3. ACPM concludes insufficient evidence to recommend routine prostate cancer screening
4. Global Summit on AIDS and the Church Begins Today and Concludes With Youth Summit on World AIDS Day:
5. Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
6. Hooper Holmes Concludes Sale of Medicals Direct
7. USA TODAY Concludes Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
8. Skinvisible Announces Licensing Agreement for Adapalene
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
11. Campbell Alliance Business Development Practice Leader to Co-Chair and Keynote at SRI Pharma Licensing Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a New Way ... Training Capability , World renown body weight trainer, Paul Ziachik, announces today ... dramatically increases a person’s training capability. , The American College of Sports Medicine ...
(Date:7/30/2015)... ... 30, 2015 , ... Boston Web Marketing is ... Google Partners is the platform for search marketing agencies to communicate with the ... necessary to run successful search marketing campaigns. Google Partners also affords businesses the ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Gummy smile ... lip lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. ... has made him popular with many patients from around the world. , “Like treatment ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of ... easy to apply lotion or medication to a hard-to-reach area. This invention is patented. ... medication to the back, and provides thorough coverage. The product would prevent the user ...
(Date:7/30/2015)... ... July 30, 2015 , ... After conducting a nationwide executive search ... Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief ... 25 years of healthcare leadership experience, Walsh is an expert in organizational change, physician ...
Breaking Medicine News(10 mins):Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5
... American Speech-Language-Hearing Association (ASHA) has announced plans to award ... of the Association for her pioneering research and academic ... Chair in Communication Disorders in the School of Behavioral ... research in the Callier Center for Communication Disorders. In ...
... INDIANAPOLIS Technologies for rapid detection of bacterial ... supply. Researchers from the School of ... the Bindley Bioscience Center at Purdue University have ... classification of harmful bacteria in food. The investigators ...
... in the Oct. 15 issue of the Journal of ... a much higher prevalence and risk of restless legs syndrome ... may improve sleep and quality of life in people with ... syndrome was about 10 times higher in the fibromyalgia group ...
... precursors of all the tissues in our body, can ... cancer. Now research from Rockefeller University shows that having ... for too long, can increase the odds of developing ... death in precursor cells for blood, or hematopoietic stem ...
... known as beta blockers have been proven to increase patients, ... workload and oxygen demand on the heart. In a breakthrough ... Medicine cardiologist Jeffrey J. Goldberger found the majority of patients ... drugs, which can put their recovery from heart attacks and ...
... HealthDay Reporter , THURSDAY, Oct. 14 (HealthDay News) ... follows all the recommended colon cancer screening guidelines, a new ... for some tests, while the remaining 40 percent don,t follow ... "There,s more work to be done to understand how to ...
Cached Medicine News:Health News:Award to honor pivotal career in speech research 2Health News:Award to honor pivotal career in speech research 3Health News:Eat safer: Novel approach detects unknown food pathogens 2Health News:Study finds a high rate of restless legs syndrome in adults with fibromyalgia 2Health News:Gene identified that prevents stem cells from turning cancerous 2Health News:Gene identified that prevents stem cells from turning cancerous 3Health News:Low beta blocker dose can put patients at risk for subsequent heart attacks 2Health News:Most Doctors Don't Follow Colon Cancer Screening Guidelines 2Health News:Most Doctors Don't Follow Colon Cancer Screening Guidelines 3
(Date:7/30/2015)... July 30, 2015  Medimetriks Pharmaceuticals, Inc. announced ... Phase III clinical study for Ozenoxacin, a novel ... owns the exclusive U.S. rights to Ozenoxacin 1% ... at 44 centers with an emphasis on U.S. ... 2 months and older with a clinical diagnosis ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... of Iomai Adjuvant ... Patch -, ... announced that it has begun dosing in a Phase 1/2,study that will ... in combination with an injected,H5N1 influenza vaccine. The Iomai patch, which ...
... Biopure Corporation,(Nasdaq: BPUR ) today announced that it ... use protocol submitted by the company in July. At,the ... for a Phase,2 randomized trial for the treatment of ... alloantibody anemia but,excluding sickle cell anemia. Hemopure has been ...
Cached Medicine Technology:Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 2Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 3Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 4Biopure Reports on Meeting with the FDA 2Biopure Reports on Meeting with the FDA 3
... implanted bone growth stimulator for the treatment ... implanted bone growth stimulator is a useful ... surgery is already planned or when patient ... OsteoGen is totally surgically implanted, patients are ...
... Stryker is proud to offer ... on the market at only ... design incorporates a superior flow ... intuitive locking mechanisms. The complementing ...
... Cryocare® CS is ... placement and treatment system ... and allow unlimited flexibility. ... to meet specific physician ...
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips....
Medicine Products: